Gassowska-Dobrowolska M, Czapski G, Cieslik M, Zajdel K, Frontczak-Baniewicz M, Babiec L
Int J Mol Sci. 2023; 24(8).
PMID: 37108467
PMC: 10138344.
DOI: 10.3390/ijms24087303.
Fang Y, Li D, Wang M, Zhao X, Duan J, Gu Q
Front Neurol. 2022; 13:863826.
PMID: 35685742
PMC: 9171393.
DOI: 10.3389/fneur.2022.863826.
Capal J, Williams M, Pearson D, Kissinger R, Horn P, Murray D
Ann Neurol. 2021; 90(6):874-886.
PMID: 34668231
PMC: 8639652.
DOI: 10.1002/ana.26249.
Schubert-Bast S, Strzelczyk A
Ther Adv Neurol Disord. 2021; 14:17562864211031100.
PMID: 34349839
PMC: 8290505.
DOI: 10.1177/17562864211031100.
McDonald N, Jeste S
Curr Psychiatry Rep. 2021; 23(6):34.
PMID: 33860866
PMC: 8765326.
DOI: 10.1007/s11920-021-01243-x.
Factors Affecting Family Compliance with Genetic Testing of Children Diagnosed with Autism Spectrum Disorder.
Hendel Y, Meiri G, Flusser H, Michaelovski A, Dinstein I, Menashe I
J Autism Dev Disord. 2020; 51(4):1201-1209.
PMID: 32651724
DOI: 10.1007/s10803-020-04589-y.
Improving Developmental Abilities in Infants With Tuberous Sclerosis Complex: A Pilot Behavioral Intervention Study.
McDonald N, Hyde C, Choi A, Gulsrud A, Kasari C, Nelson 3rd C
Infants Young Child. 2020; 33(2):108-118.
PMID: 32467653
PMC: 7255424.
DOI: 10.1097/iyc.0000000000000160.
Chronic activation of anti-oxidant pathways and iron accumulation in epileptogenic malformations.
Zimmer T, Ciriminna G, Arena A, Anink J, Korotkov A, Jansen F
Neuropathol Appl Neurobiol. 2019; 46(6):546-563.
PMID: 31869431
PMC: 7308211.
DOI: 10.1111/nan.12596.
Resting-State fMRI Networks in Children with Tuberous Sclerosis Complex.
Ahtam B, Dehaes M, Sliva D, Peters J, Krueger D, Bebin E
J Neuroimaging. 2019; 29(6):750-759.
PMID: 31304656
PMC: 7020733.
DOI: 10.1111/jon.12653.
Early Clinical Predictors of Autism Spectrum Disorder in Infants with Tuberous Sclerosis Complex: Results from the EPISTOP Study.
Moavero R, Benvenuto A, Emberti Gialloreti L, Siracusano M, Kotulska K, Weschke B
J Clin Med. 2019; 8(6).
PMID: 31163675
PMC: 6617179.
DOI: 10.3390/jcm8060788.
A Synaptic Perspective of Fragile X Syndrome and Autism Spectrum Disorders.
Bagni C, Zukin R
Neuron. 2019; 101(6):1070-1088.
PMID: 30897358
PMC: 9628679.
DOI: 10.1016/j.neuron.2019.02.041.
Disruption of mTOR and MAPK pathways correlates with severity in idiopathic autism.
Rosina E, Battan B, Siracusano M, Di Criscio L, Hollis F, Pacini L
Transl Psychiatry. 2019; 9(1):50.
PMID: 30705255
PMC: 6355879.
DOI: 10.1038/s41398-018-0335-z.
A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).
de Vries P, Wilde L, de Vries M, Moavero R, Pearson D, Curatolo P
Am J Med Genet C Semin Med Genet. 2018; 178(3):309-320.
PMID: 30117265
PMC: 6209538.
DOI: 10.1002/ajmg.c.31637.
Corticostriatal Transmission Is Selectively Enhanced in Striatonigral Neurons with Postnatal Loss of Tsc1.
Benthall K, Ong S, Bateup H
Cell Rep. 2018; 23(11):3197-3208.
PMID: 29898392
PMC: 6089242.
DOI: 10.1016/j.celrep.2018.05.037.
Surgery for subependymal giant cell astrocytomas in children with tuberous sclerosis complex.
Fohlen M, Ferrand-Sorbets S, Delalande O, Dorfmuller G
Childs Nerv Syst. 2018; 34(8):1511-1519.
PMID: 29766265
DOI: 10.1007/s00381-018-3826-6.
Cortical dysplasia and autistic trait severity in children with Tuberous Sclerosis Complex: a clinical epidemiological study.
Mous S, Overwater I, Vidal Gato R, Duvekot J, Ten Hoopen L, Lequin M
Eur Child Adolesc Psychiatry. 2017; 27(6):753-765.
PMID: 29063203
PMC: 5973967.
DOI: 10.1007/s00787-017-1066-z.
New insights into the pathogenesis and prevention of tuberous sclerosis-associated neuropsychiatric disorders (TAND).
Gipson T, Johnston M
F1000Res. 2017; 6.
PMID: 28663780
PMC: 5473405.
DOI: 10.12688/f1000research.11110.1.
Risk factors for the development of autism spectrum disorder in children with tuberous sclerosis complex: protocol for a systematic review.
Mitchell R, Barton S, Harvey A, Williams K
Syst Rev. 2017; 6(1):49.
PMID: 28270230
PMC: 5341363.
DOI: 10.1186/s13643-017-0448-0.
Clinical Usefulness of Aripiprazole and Lamotrigine in Schizoaffective Presentation of Tuberous Sclerosis.
Lee S, Min J, Lee I, Kim J
Clin Psychopharmacol Neurosci. 2016; 14(3):305-10.
PMID: 27489387
PMC: 4977818.
DOI: 10.9758/cpn.2016.14.3.305.
Symptom profiles of autism spectrum disorder in tuberous sclerosis complex.
Jeste S, Varcin K, Hellemann G, Gulsrud A, Bhatt R, Kasari C
Neurology. 2016; 87(8):766-72.
PMID: 27440144
PMC: 4999317.
DOI: 10.1212/WNL.0000000000003002.